Medical News

RSS

IRSF announces first 2010 ANGEL Grant for testing potential Rett Syndrome therapies

Today, the International Rett Syndrome Foundation (IRSF) announced that it will commit $446,000 in 2010 to fund a large translational research program to test potential therapeutics for Rett Syndrome in mouse models of the disease. The funds will be awarded through the IRSF's new Advanced Neurotherapeutic Grant of Excellence (ANGEL) mechanism which seeks to provide funds for translational research. IRSF is the world's largest private source of Rett syndrome research funding, supporting nearly $21 million in research programs to date. This is the first ANGEL Grant supported by IRSF in 2010.

28 Jan 2010

NCHC Action Fund calls for redoubling efforts to enact comprehensive health system reform

The effort to fix our dysfunctional, inequitable and unsustainable health system is at a crucial juncture. Without prompt and decisive leadership, defeat, as it has for over a century, will again prevail over reform.

28 Jan 2010

Survey: Health care reform would lead to higher costs for employer-sponsored benefit programs

A significant majority of U.S. employers believe health care reform, if enacted, would lead to higher costs for both employer-sponsored benefit programs and health care services overall, according to initial results from an employer survey conducted by Towers Watson and the National Business Group on Health.

28 Jan 2010

ALS TDI and Oxford BioMedica extend collaboration to develop gene therapies for Lou Gehrig's disease

The ALS Therapy Development Institute and Oxford BioMedica announced today the extension of their collaboration following successful completion of the first phase. The extended collaboration, which is funded by the Muscular Dystrophy Association, aims to advance the development of Oxford BioMedica's preclinical gene therapy candidate, MoNuDin®, and to evaluate other gene-based strategies for the treatment of amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease).

28 Jan 2010

Inovio Biomedical unveils new clinical-grade, miniaturized electroporation device

Inovio Biomedical Corporation, a leader in DNA vaccine design, development and delivery, today unveiled its new clinical-grade, miniaturized electroporation device designed to be an easy-to-use, portable delivery product for DNA vaccines.

28 Jan 2010

Abiomed integrates Opsens’ sensor technology into its Impella catheter

Abiomed, Inc., a leading provider of breakthrough heart support technologies designed for heart recovery, today announced a strategic partnership with Opsens, a leading developer of fiber optic sensors. Through this partnership, Opsens’ breakthrough sensor technology will be integrated into the Impella® catheter to provide robust blood pressure measurements that can be used to enhance Impella’s performance and ease-of-use.

28 Jan 2010

Researchers urge for a national health trust for personal and public health

The United States has an inefficient and expensive health care system, but it could be improved with a new integrated health care system detailed in a new study in the American Journal of Public Health (February 2010 Vol. 100 No. 2).

28 Jan 2010

UC-CCHMC partnership receives $3.75M NIAMS grant for musculoskeletal soft tissue repair research

An award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) will aid a partnership between the University of Cincinnati (UC) and Cincinnati Children's Hospital Medical Center (CCHMC) in finding new ways to use adult stem cells to speed repair of musculoskeletal soft tissue injuries.

28 Jan 2010

Three insurance providers purchase licenses under patent portfolio held by Ronald A. Katz Technology Licensing

Ronald A. Katz Technology Licensing, L.P. announced today that three leading providers of insurance services have purchased licenses under the patent portfolio held by Ronald A. Katz Technology Licensing, L.P. and licensed through its affiliate, A2D, L.P.

28 Jan 2010

MDS receives provisional anti-trust approval to sell MDS Analytical Technologies to Danaher

MDS Inc., a leading provider of products and services to the global life sciences markets, today announced that the Company has received provisional anti-trust approval from the United States Federal Trade Commission (FTC) for the proposed sale of MDS Analytical Technologies to Danaher Corporation.

From Danaher 28 Jan 2010

Health organizations urge Congress to protect Medicare beneficiaries' access to critical rehabilitative services

A coalition of organizations representing consumers, health professionals and providers recently sent a letter to Congressional Leadership, calling for the immediate reinstatement of the exceptions process for Medicare Part B outpatient therapy services. Without such efforts, thousands of Medicare beneficiaries will exceed arbitrary limitations on physical therapy, occupational therapy, and speech-language pathology services.

28 Jan 2010

MedCI forms new strategic alliance with Genta

MedCI LLC, a life-science business consulting services company, announced the formation of a new strategic alliance with Genta Incorporated to secure licensing partners for Genta’s small molecule oncology compound, tesetaxel.

28 Jan 2010

CSCs elimination could hold the key to fight ovarian cancer

Eliminating cancer stem cells (CSCs) within a tumor could hold the key to successful treatments for ovarian cancer, which has been notoriously difficult to detect and treat, according to new findings published this week in the journal Oncogene by Yale School of Medicine researchers.

28 Jan 2010

Greg Morgan awarded the Derek Price/Rod Webster Prize

Greg Morgan, an Associate Professor of Philosophy at Stevens Institute of Technology, was recently awarded the Derek Price/Rod Webster Prize for best paper of 2009 in History of Science by the History of Science Society.

28 Jan 2010

NIH to perform exploratory studies on ImmuneRegen BioSciences' Homspera

ImmuneRegen BioSciences Inc.®, a wholly owned subsidiary of IR Biosciences Holdings Inc. (OTCBB: IRBS), today announced the execution of an agreement with the National Institute of Health (NIH) / National Cancer Institute (NCI) to commence studies utilizing ImmuneRegen's Homspera.

28 Jan 2010

Also in global health news: Pakistan's farm land; PMTCT in Kenya; Burkina Faso's maternal health; health care access in Middle East

Pakistan's Foreign Minister Shah Mehmood Qureshi said Tuesday the country plans to sell farmland to foreign investors despite warnings by the U.N. that doing so could compromise farmers' rights, Reuters reports.

28 Jan 2010

Neomend completes $30M Series D funding round

Neomend, Inc., an innovator in sealant and adhesion-prevention products for the surgical marketplace, announced today it has completed a funding round of $30 million, with Clarus Ventures, LLC investing $17 million.

28 Jan 2010

Research shows even mild to moderate kidney disease may diminish child's quality of life

Challenging prevailing wisdom that only children with end-stage kidney disease suffer physical, social, emotional and educational setbacks from their disease, research led by Johns Hopkins Children's Center shows that even mild to moderate kidney disease may seriously diminish a child's quality of life.

28 Jan 2010

NewsRx publishes new encyclopedia on vaccines

NewsRx, a 25-year-old publisher and international news organization headquartered in Atlanta, has published a new encyclopedia on vaccines -- Encyclopedia of Vaccines, 2009: An encyK Resource for Parents, Patients & Professionals.

28 Jan 2010

Electrode devices emerge as potential stimulation treatments for depression

Approximately ten to thirty percent of patients with depression do not respond to drug treatments commonly used for the disorder, and this has spurred a search for alternatives. According to Kalorama Information's report "Electrical and Magnetic Neurostimulation," electrode devices that stimulate nerves have emerged as a solution and there is competition among notable device companies to provide the most effective stimulator.

28 Jan 2010

Medical News

IRSF announces first 2010 ANGEL Grant for testing potential Rett Syndrome therapies

NCHC Action Fund calls for redoubling efforts to enact comprehensive health system reform

Survey: Health care reform would lead to higher costs for employer-sponsored benefit programs

ALS TDI and Oxford BioMedica extend collaboration to develop gene therapies for Lou Gehrig's disease

Inovio Biomedical unveils new clinical-grade, miniaturized electroporation device

Abiomed integrates Opsens’ sensor technology into its Impella catheter

Researchers urge for a national health trust for personal and public health

UC-CCHMC partnership receives $3.75M NIAMS grant for musculoskeletal soft tissue repair research

Three insurance providers purchase licenses under patent portfolio held by Ronald A. Katz Technology Licensing

MDS receives provisional anti-trust approval to sell MDS Analytical Technologies to Danaher

Health organizations urge Congress to protect Medicare beneficiaries' access to critical rehabilitative services

MedCI forms new strategic alliance with Genta

CSCs elimination could hold the key to fight ovarian cancer

Greg Morgan awarded the Derek Price/Rod Webster Prize

NIH to perform exploratory studies on ImmuneRegen BioSciences' Homspera

Also in global health news: Pakistan's farm land; PMTCT in Kenya; Burkina Faso's maternal health; health care access in Middle East

Neomend completes $30M Series D funding round

Research shows even mild to moderate kidney disease may diminish child's quality of life

NewsRx publishes new encyclopedia on vaccines

Electrode devices emerge as potential stimulation treatments for depression

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News